Publication

Perivascular M2 macrophages stimulate tumor relapse after chemotherapy

Related publications (39)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Perivascular M2 macrophages stimulate tumor relapse after chemotherapy

Graph Chatbot

Chat with Graph Search

Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions

Elucidating the role of lymphatic vessels within the tumor microenvironment of breast cancer

Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events

The selective Tie2 inhibitor rebastinib blocks recruitment and function of Tie2Hi macrophages in breast cancer and neuroendocrine pancreatic tumors

Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade

TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer

SiNW-based Biosensors for Profiling Biomarkers in Breast Tumor Tissues

Debio 0617B Inhibits Growth of STAT3-Driven Solid Tumors through Combined Inhibition of JAK, SRC, and Class III/V Receptor Tyrosine Kinases

Radiologic evaluation of lumps in the male breast

Targeting Vascular Pericytes in Hypoxic Tumors Increases Lung Metastasis via Angiopoietin-2